Suresh Senan, MRCP, FRCR, PhD
The European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC) have announced the 2016 Heine H. Hansen (HHH) Award recipient: Suresh Senan, MRCP, FRCR, PhD. The award was presented at the European Lung Cancer Conference (ELCC) 2016, held on April 13–16 in Geneva, Switzerland.
The HHH Award recognizes the lifetime contribution of Heine H. Hansen, MD, PhD, FRCP, to lung cancer research and education globally. Heine Hansen was a President of ESMO, a founder of IASLC and a mentor to many in the field of lung cancer. The HHH Award is presented annually by representatives of both organizations at ELCC.
The HHH Award acknowledges a lung cancer investigator who has made a special contribution to lung cancer research and education on an international basis. Dr. Senan is currently Vice-Chair of the Department of Radiation Oncology at the VU University Medical Centre in Amsterdam, the Netherlands, where he is also Professor of Clinical Experimental Radiotherapy. He is an ESMO faculty member for chest tumors and has been a member of IASLC since 2000.
Commenting on the significance of receiving the award, Dr. Senan said, “The Heine H. Hansen Award reflects the opportunities provided by ESMO to nonmedical oncologists such as myself to actively participate in guideline development and teaching courses, all with the aim of contributing to improved care for our patients.”
Dr. Senan’s research has focused on different aspects of lung cancer therapy, including stereotactic radiotherapy; four-dimensional imaging; chemoradiotherapy; treatment of small cell lung cancer; comparative effectiveness research; and magnetic resonance imaging–guided treatment.
Dr. Senan completed training in internal medicine at the National University of Singapore before training in radiotherapy and oncology in Scotland. ■
